AEON (AEON Biopharma, Inc.) Stock Analysis - SEC Filings

AEON Biopharma, Inc. (AEON) is a publicly traded Healthcare sector company. As of May 21, 2026, AEON trades at $0.86 with a market cap of $22.49M and a P/E ratio of -0.22. AEON moved +0.91% today. Year to date, AEON is -23.64%; over the trailing twelve months it is +69.63%. Its 52-week range spans $0.38 to $115.57. Rallies surfaces AEON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find AEON SEC filings?

Rallies organizes AEON SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

AEON Key Metrics

Key financial metrics for AEON
MetricValue
Price$0.86
Market Cap$22.49M
P/E Ratio-0.22
EPS$-3.95
Dividend Yield0.00%
52-Week High$115.57
52-Week Low$0.38
Volume553
Avg Volume0
Revenue (TTM)$0
Net Income$-39.22M
Gross Margin0.00%

Latest AEON News

Recent AEON Insider Trades

  • FISCHER JOST bought 60.00K (~$29.25K) on May 21, 2025.
  • FISCHER JOST bought 60.00K (~$30.36K) on May 20, 2025.
  • FISCHER JOST bought 50.00K (~$24.94K) on May 19, 2025.

AEON Analyst Consensus

AEON analyst coverage data. Average price target: $0.00.

Common questions about AEON

Where can I find AEON SEC filings?
Rallies organizes AEON SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show AEON 10-K and 10-Q filings?
Rallies organizes AEON SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is AEON research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AEON. It does not provide personalized investment advice.
AEON

AEON